1094 100% SVR IN IL28B CC PATIENTS TREATED WITH 12 WEEKS OF TELAPREVIR, PEGINTERFERON AND RIBAVIRIN IN THE PROVE2 TRIAL

Authors :: Jean-Pierre Zarski
Martyn Botfield
Christophe Hézode
V. de Ledinghen
Stanislas Pol
P. Mathurin
Albert Tran
Yves Benhamou
C. Trepo
Jean-Didier Grangé
Leif Bengtsson
S. Seepersaud
M. Bourlière
K. Kelliher
Patrick Marcellin
Lawrence Serfaty
Jean-Pierre Bronowicki
J.-M. Pawlotsky
Source :: Journal of Hepatology. 56:S430-S431
Publication Year :: 2012
Publisher :: Elsevier BV, 2012.

Subjects :: medicine.medical_specialty
chemistry.chemical_compound
Hepatology
chemistry
business.industry
Internal medicine
Ribavirin
medicine
business
Gastroenterology
Telaprevir
medicine.drug

Tools